glp 1 pet scan A) 68 Ga-DOTATATE PET/CT. Mild focal uptake in pancreatic tail Impaired brain glucose metabolism in

Experience enhanced vitality and well being through peptide therapy

Hernndez-Saavedra D, Hinkley JM, Baer LA, Pinckard KM, Vidal P, Nirengi S, et al

Thm ch, qu liu vitamin B9 cn tng nguy c ti pht ung th vi nhng bnh nhn tng c chn on mc ung th i trc trng hoc ung th tuyn tin lit

Several methods are introduced to increase the half-life of GLP-1 including: (i) modifying peptides to make them resistant to cleavage by DPP-4, such as exenatide twice daily and lixisenatide, (ii) attaching free fatty acid side chains to liraglutide and semaglutide, which enhances their binding to plasma albumin thereby preventing renal filtration of GLP-1 and prolonging their action in vivo [36, 37], (iii) conjugation of albumin or the Fc fragment of IgG to GLP-1 molecule is used in albiglutide and dulaglutide [37, 38], (iv) development of modified nanoparticles for the controlled release of exenatide-LAR (long-acting release) that provide prolonged release of the peptide [39], and finally, (v) chemical permeation enhancers such as sodium salcaprozate (SNAC) could be utilized to overcome the low permeability and high enzymatic degradation of the gastrointestinal tract of GLP-1 analog that is administrated orally such as semaglutide [40]